The Science of Changing Lives. Since its inception in 2014, GSL has developed disruptive technologies in the biotech and related industries. GSL’s goal is to commercialize these technologies via its various subsidiaries. My Next Health (“MNH”) is an innovative healthcare company with a vision to improve the global healthcare sector by deploying an innovative genomic-based AI and quantum platform for clinical trials, point of care solutions and personalized consumer health.